Rote-Hand-Brief: Respreeza (humaner Alpha-1-Proteinase-Inhibitor)
Safety Classified by Officially
Risiko einer Dosisauslassung und potenzieller Infektionen aufgrund einer beeinträchtigten Integrität des Primärbehältnisses
Source: Paul-Ehrlich-Institut.
Read the original at the source: https://www.pei.de/DE/newsroom/veroffentlichungen-arzneimittel/sicherheitsinformationen-human/2026/ablage2026/2026-10-30-rhb-respreeza.html
Officially imported this from Paul-Ehrlich-Institut’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Paul-Ehrlich-Institut — imported from official source
- Official source
- https://www.pei.de/SiteGlobals/Functions/RSSFeed/RSSGenerator_Sicherheitsinformationen.xml?nn=168758 RSS
- Imported
- October 30, 2026 11:30
- Versions
- 1 recorded
- Identity
-
https://www.pei.de/DE/newsroom/veroffentlichungen-arzneimittel/sicherheitsinformationen...